Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma. Liu S, Guan T, Yang F, Zhang H, et al. BMC Cancer 2025;25:593.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu S, Guan T, Yang F, Zhang H, et al. Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma. BMC Cancer 2025;25:593.
PMID: 40169956